1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Germany >
  5. Hitachi Chemical Advanced Therapeutics Solutions Acquires apceth Biopharma

M&A Deal Summary

Hitachi Chemical Advanced Therapeutics Solutions Acquires apceth Biopharma

On January 31, 2019, Hitachi Chemical Advanced Therapeutics Solutions acquired life science company apceth Biopharma

Acquisition Highlights
  • This is Hitachi Chemical Advanced Therapeutics Solutions’ 1st transaction in the Life Science sector.
  • This is Hitachi Chemical Advanced Therapeutics Solutions’ 1st transaction in Germany.

M&A Deal Summary
Date 2019-01-31
Target apceth Biopharma
Sector Life Science
Buyer(s) Hitachi Chemical Advanced Therapeutics Solutions
Deal Type Add-on Acquisition

Target

apceth Biopharma

Ottobrunn, Germany
apceth Biopharma GmbH is a contract manufacturer of cell and gene therapy products. apceth Biopharma is based in Ottobrunn, Germany.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Hitachi Chemical Advanced Therapeutics Solutions

Allendale, New Jersey, United States
Category Company
Sector Chemicals
DESCRIPTION

Hitachi Chemical Advanced Therapeutics Solutions LLC is a contract development and manufacturing organization (CDMO) services at current Good Manufacturing Practices (cGMP) standards, including clinical manufacturing, commercial manufacturing, and manufacturing development.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Germany M&A 1 of 1
Year: 2019 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal